United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape
The United States generic drugs market is expected to grow at a CAGR of around 9.3% during 2025-2034. This report on United States generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting the market based on type, therapy area, drug delivery, and distribution channel. Also, detailed profiles of companies operating in the United States generic drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Prevalence of Chronic Diseases
• Growth in Geriatric Population
• Increasing Investments in Advertising
Market Challenges
• Stringent Governmental Regulations
• Adverse Effects Associated With Drugs
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Type
• Unbranded
• Branded
Market by Therapy Area
• CNS
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others
Market by Drug Delivery
• Oral
• Injectable
• Dermal/Topical
• Inhalers
Market by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. United States Generic Drugs Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. United States Generic Drugs Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 5. United States Generic Drugs Market by Type
- 5.1. Introduction
- 5.2 Unbranded
- 5.3 Branded
- 6. United States Generic Drugs Market by Therapy Area
- 6.1 Introduction
- 6.2 CNS
- 6.3 Cardiovascular
- 6.4 Dermatology
- 6.5 Genitourinary/Hormonal
- 6.6 Respiratory
- 6.7 Rheumatology
- 6.8 Diabetes
- 6.9 Oncology
- 6.10 Others
- 7. United States Generic Drugs Market by Drug Delivery
- 7.1 Introduction
- 7.2 Oral
- 7.3 Injectable
- 7.4 Dermal/Topical
- 7.5 Inhalers
- 8. United States Generic Drugs Market by Distribution Channel
- 8.1 Introduction
- 8.2 Hospital Pharmacies
- 8.3 Retail Pharmacies
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1 Competitive Scenario
- 12.2 Company Profiles
- 12.2.1 Teva
- 12.2.2 Mylan
- 12.2.3 Actavis (Teva)
- 12.2.4 Sandoz (Novartis)
- 12.2.5 Sun Pharma
- 12.2.6 Par Pharmaceuticals (Endo Pharmaceuticals)
- 12.2.7 Lupin Pharmaceuticals
- 12.2.8 Dr Reddy’s
- 12.2.9 Hospira (Pfizer)
- 12.2.10 Baxter International Inc
- 12.2.11 GlaxoSmithKline Plc.
- 12.2.12 Eli Lilly and Company
- 12.2.13 ALLERGAN
- 12.2.14 STADA Arzneimittel AG
- 12.2.15 Abbott Laboratories
- List of Figures
- Figure 1: United States Generic Drugs Market (in US$ Million), 2020-2024
- Figure 2: United States Generic Drugs Market by Type, 2024
- Figure 3: United States Generic Drugs Market by Therapy Area, 2024
- Figure 4: United States Generic Drugs Market by Drug Delivery, 2024
- Figure 5: United States Generic Drugs Market by Distribution Channel, 2024
- Figure 6: United States Generic Drugs Market (in US$ Million), 2025-2034
- Figure 7: United States Generic Drugs Market by Type (in %), 2024 & 2034
- Figure 8: United States Unbranded Generic Drugs Market (in US$ Million), 2020-2024
- Figure 9: United States Unbranded Generic Drugs Market (in US$ Million), 2025-2034
- Figure 10: United States Branded Generic Drugs Market (in US$ Million), 2020-2024
- Figure 11: United States Branded Generic Drugs Market (in US$ Million), 2025-2034
- Figure 12: United States Generic Drugs Market by Therapy Area (in %), 2024 & 2034
- Figure 13: United States CNS Generic Drugs Market (in US$ Million), 2020-2024
- Figure 14: United States CNS Generic Drugs Market (in US$ Million), 2025-2034
- Figure 15: United States Cardiovascular Generic Drugs Market (in US$ Million), 2020-2024
- Figure 16: United States Cardiovascular Generic Drugs Market (in US$ Million), 2025-2034
- Figure 17: United States Dermatology Generic Drugs Market (in US$ Million), 2020-2024
- Figure 18: United States Dermatology Generic Drugs Market (in US$ Million), 2025-2034
- Figure 19: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2020-2024
- Figure 20: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2025-2034
- Figure 21: United States Respiratory Generic Drugs Market (in US$ Million), 2020-2024
- Figure 22: United States Respiratory Generic Drugs Market (in US$ Million), 2025-2034
- Figure 23: United States Rheumatology Generic Drugs Market (in US$ Million), 2020-2024
- Figure 24: United States Rheumatology Generic Drugs Market (in US$ Million), 2025-2034
- Figure 25: United States Diabetes Generic Drugs Market (in US$ Million), 2020-2024
- Figure 26: United States Diabetes Generic Drugs Market (in US$ Million), 2025-2034
- Figure 27: United States Oncology Generic Drugs Market (in US$ Million), 2020-2024
- Figure 28: United States Oncology Generic Drugs Market (in US$ Million), 2025-2034
- Figure 29: United States Others Generic Drugs Market (in US$ Million), 2020-2024
- Figure 30: United States Others Generic Drugs Market (in US$ Million), 2025-2034
- Figure 31: United States Generic Drugs Market by Drug Delivery (in %), 2024 & 2034
- Figure 32: United States Oral Generic Drugs Market (in US$ Million), 2020-2024
- Figure 33: United States Oral Generic Drugs Market (in US$ Million), 2025-2034
- Figure 34: United States Injectable Generic Drugs Market (in US$ Million), 2020-2024
- Figure 35: United States Injectable Generic Drugs Market (in US$ Million), 2025-2034
- Figure 36: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2020-2024
- Figure 37: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2025-2034
- Figure 38: United States Inhalers Generic Drugs Market (in US$ Million), 2020-2024
- Figure 39: United States Inhalers Generic Drugs Market (in US$ Million), 2025-2034
- Figure 40: United States Generic Drugs Market by Distribution Channel (in %), 2024 & 2034
- Figure 41: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2020-2024
- Figure 42: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2025-2034
- Figure 43: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2020-2024
- Figure 44: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2025-2034
- Figure 45: Market Value Chain
- List of Tables
- Table 1: United States Generic Drugs Market Portraiture
- Table 2: United States Generic Drugs Market by Type (in US$ Million), 2024 & 2034
- Table 3: United States Generic Drugs Market by Therapy Area (in US $ Million), 2024 & 2034
- Table 4: United States Generic Drugs Market by Drug Delivery (in US $ Million), 2024 & 2034
- Table 5: United States Generic Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
- Table 6: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook